SEARCH

SEARCH BY CITATION

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Amir Kasraianfard, Kymberly D. Watt, Lance Lindberg, Sophoclis Alexopoulos, Nima Rezaei, HBIG Remains Significant in the Era of New Potent Nucleoside Analogues for Prophylaxis Against Hepatitis B Recurrence After Liver Transplantation, International Reviews of Immunology, 2015, 1

    CrossRef

  2. 2
    Eva Hulstaert, Xavier Verhelst, Anja Geerts, Hans Van Vlierberghe, Intramuscular hepatitis B immunoglobulins for reinfection control after liver transplantation: a cost-saving alternative, Journal of Comparative Effectiveness Research, 2015, 4, 3, 259

    CrossRef

  3. 3
    Saro Khemichian, Mary J. Hsieh, Shi-Rong Zhang, Joyce Limurti, John Kim, Tse-Ling Fong, Nucleoside–Nucleotide Analog Combination Therapy Is Effective in Preventing Recurrent Hepatitis B After Liver Transplantation, Digestive Diseases and Sciences, 2015, 60, 9, 2807

    CrossRef

  4. 4
    Bruno Roche, Didier Samuel, Prevention of Post-transplant HBV, Current Hepatology Reports, 2015, 14, 3, 153

    CrossRef

  5. 5
    Akinobu Takaki, Takahito Yagi, Kazuhide Yamamoto, Safe and cost-effective control of post-transplantation recurrence of hepatitis B, Hepatology Research, 2015, 45, 1
  6. 6
    I. Fernández, C. Loinaz, O. Hernández, M. Abradelo, A. Manrique, J. Calvo, M. Manzano, A. García, F. Cambra, G. Castellano, C. Jiménez, Tenofovir/entecavir monotherapy after hepatitis B immunoglobulin withdrawal is safe and effective in the prevention of hepatitis B in liver transplant recipients, Transplant Infectious Disease, 2015, 17, 5
  7. 7
    Experimental and Clinical Transplantation, 2015, 13, Suppl 1

    CrossRef

  8. 8
    Akinobu Takaki, Takahito Yagi, Kazuhide Yamamoto, Contradictory Immune Response in Post Liver Transplantation Hepatitis B and C, International Journal of Inflammation, 2014, 2014, 1

    CrossRef

  9. 9
    Evangelos Cholongitas, Ioannis Goulis, Nikolaos Antoniadis, Ioannis Fouzas, George Imvrios, Vasilios Papanikolaou, Evangelos Akriviadis, New nucleos(t)ide analogue monoprophylaxis after cessation of hepatitis B immunoglobulin is effective against hepatitis B recurrence, Transplant International, 2014, 27, 10
  10. 10
    Gun Hyung Na, Dong Goo Kim, Jae Hyun Han, Eun Young Kim, Soo Ho Lee, Tae Ho Hong, Young Kyoung You, Jong Young Choi, Prevention and risk factors of hepatitis B recurrence after living donor liver transplantation, Journal of Gastroenterology and Hepatology, 2014, 29, 1
  11. 11
    Benjamin Lee, Marian G. Michaels, Prophylactic antimicrobials in solid organ transplant, Current Opinion in Critical Care, 2014, 20, 4, 420

    CrossRef

  12. 12
    Geoffrey W. McCaughan, Current Management of HBV Pre and Post Liver Transplant, Current Hepatitis Reports, 2013, 12, 2, 119

    CrossRef

  13. 13
    Robert Perrillo, Maria Buti, Francois Durand, Michael Charlton, Adrian Gadano, Guido Cantisani, Che-Chuan Loong, Kimberly Brown, Wenhua Hu, Juan Carlos Lopez-Talavera, Cyril Llamoso, Entecavir and hepatitis B immune globulin in patients undergoing liver transplantation for chronic hepatitis B, Liver Transplantation, 2013, 19, 8
  14. 14
    Susanne Beckebaum, Iyad Kabar, Vito R. Cicinnati, Hepatitis B and C in liver transplantation: new strategies to combat the enemies, Reviews in Medical Virology, 2013, 23, 3
  15. 15
    E. Cholongitas, G.V. Papatheodoridis, High Genetic Barrier Nucleos(t)ide Analogue(s) for Prophylaxis From Hepatitis B Virus Recurrence After Liver Transplantation: A Systematic Review, American Journal of Transplantation, 2013, 13, 2
  16. 16
    D.J.W. Wesdorp, M. Knoester, A.E. Braat, M.J. Coenraad, A.C.T.M. Vossen, E.C.J. Claas, B. van Hoek, Nucleoside plus nucleotide analogs and cessation of hepatitis B immunoglobulin after liver transplantation in chronic hepatitis B is safe and effective, Journal of Clinical Virology, 2013, 58, 1, 67

    CrossRef

  17. 17
    Nam-Joon Yi, Jong Young Choi, Kyung-Suk Suh, Jai Young Cho, Minjung Baik, Geun Hong, Kwang-Woong Lee, Won Kim, Yoon Jun Kim, Jung-Hwan Yoon, Hyo-Suk Lee, Dong Goo Kim, Post-transplantation sequential entecavir monotherapy following 1-year combination therapy with hepatitis B immunoglobulin, Journal of Gastroenterology, 2013, 48, 12, 1401

    CrossRef

  18. 18
    Tiffany CL Wong, James YY Fung, Chung Mau Lo, Prevention of recurrent hepatitis B infection after liver transplantation, Hepatobiliary & Pancreatic Diseases International, 2013, 12, 5, 465

    CrossRef

  19. 19
    Lewis W. Teperman, Fred Poordad, Natalie Bzowej, Paul Martin, Surakit Pungpapong, Thomas Schiano, John Flaherty, Phillip Dinh, Stephen Rossi, G. Mani Subramanian, James Spivey, Randomized trial of emtricitabine/tenofovir disoproxil fumarate after hepatitis B immunoglobulin withdrawal after liver transplantation, Liver Transplantation, 2013, 19, 6
  20. 20
    Katrina H. McGonigal, Iman E. Bajjoka, Marwan S. Abouljoud, Tenofovir-Emtricitabine Therapy for the Prevention of Hepatitis B Recurrence in Four Patients After Liver Transplantation, Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy, 2013, 33, 9
  21. 21
    Harald Farnik, Christoph Sarrazin, Behandlung von Lebertransplantationspatienten mit chronischer Virushepatitis, Viszeralmedizin, 2012, 28, 5, 304

    CrossRef

  22. 22
    Rishab K. Gupta, Mark C. Glassy, Oligoclonal and Polyclonal Antibody Preparations,
  23. 23
    Samir Parekh, James R. Spivey, Recurrent Disease after Liver Transplantation,